Screening

Prostate cancer screening

Do not offer systematically

INESSS 2017 still clinic default, still in September 2024 GAP. No organized program.

Screening

On request only
  • INESSS Institut national d'excellence en santé et services sociaux
  • ULaval Université Laval (decision box)
  • CTFPHC Canadian Task Force on Preventive Health Care
DecisionGuideline
On request
Differs
If requested, 55–69 AND life expectancy >10 yearsAfter shared decision.
  • Laval decision box listed in September 2024 GAP.
  • Do not start before 55 or at 70+ on INESSS.
  • LUTS is diagnostic, not this page.

INESSS APS opens in a new tabClinician tool opens in a new tabGAP September 2024 opens in a new tabLaval decision box opens in a new tab

Against PSA all ages Strong <55 and ≥70, weak 55–69.

CTFPHC 2014

Investigate

If PSA done

Open the INESSS tool.

  • INESSS Institut national d'excellence en santé et services sociaux
DecisionGuideline
If PSA done
<1.5 ng/mL
Repeat every 2–4 years

INESSS 2017 opens in a new tab

1.5–4.0
Every 1–2 years

INESSS 2017 opens in a new tab

≥4.0
Repeat within 8 weeks, then urology if still ≥4.0

INESSS 2017 opens in a new tab

Exam and tool
Couple with digital rectal exam
  • DRE alone not shown to help.
  • Link tool, do not copy table.

INESSS 2017 opens in a new tab

Higher risk

Evidence unclear
  • INESSS Institut national d'excellence en santé et services sociaux
  • CTFPHC Canadian Task Force on Preventive Health Care
DecisionGuideline
Black ancestry or strong family history
Differs
Evidence for different age or interval unclear
  • Still shared decision.
  • No organized high-risk stream.

INESSS 2017

Against PSA all ages

CTFPHC 2014

Reviewed 24 August 2026 against the official sources below.

Sources

Blue square: Québec · red round: Canada. The code names the body; each section's key gives its full name.